Roche’s Tecentriq notches win in breast cancer with US approval
The FDA’s OK was based on a trial that showed the drug cocktail helped stave off the disease’s advance by a median 7.4 months,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.